RGEN:NASDAQRepligen Corporation Analysis
Data as of 2026-07-08 - not real-time
$137.41
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Repligen posted solid double‑digit revenue growth and improved margins, supported by a strong cash position that exceeds its debt load. However, earnings per share remain modest and the company carries a high debt‑to‑equity ratio, which tempers the upside from its growth narrative.
Technical indicators show a neutral price trend but a bearish MACD crossover and a widening histogram, while market sentiment is extremely bullish, pushing the stock well above its discounted cash‑flow estimate. The combination of an elevated price multiple, high volatility and a substantial drawdown history signals that the current price may be stretched, suggesting caution for short‑term traders despite the underlying business momentum.
Technical indicators show a neutral price trend but a bearish MACD crossover and a widening histogram, while market sentiment is extremely bullish, pushing the stock well above its discounted cash‑flow estimate. The combination of an elevated price multiple, high volatility and a substantial drawdown history signals that the current price may be stretched, suggesting caution for short‑term traders despite the underlying business momentum.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- bearish MACD histogram
- price near recent support level
- significant overvaluation relative to peers
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- steady revenue growth and margin expansion
- high cash generation offset by debt load
- persistent market enthusiasm keeping price elevated
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- strong fundamentals in a growing bioprocessing market
- absence of dividend limits total return expectations
- valuation gap suggests price correction before long‑term upside
Key Metrics & Analysis
Financial Health
Revenue Growth14.80%
Profit Margin6.73%
P/E Ratio151.0
ROE2.51%
ROA1.18%
Debt/Equity32.66
P/B Ratio3.7
Op. Cash Flow$130.7M
Free Cash Flow$68.7M
Industry P/E29.2
Technical Analysis
TrendNeutral
RSI55.5
Support$124.85
Resistance$149.05
MA 20$135.50
MA 50$124.49
MA 200$139.32
MACDBearish
VolumeIncreasing
Fear & Greed Index91.25
Valuation
Fair Value$31.13
Target Price$177.05
Upside/Downside28.85%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.24
Volatility51.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.